Compare MESO & AMPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MESO | AMPL |
|---|---|---|
| Founded | 2004 | 2012 |
| Country | Australia | United States |
| Employees | 108 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2005 | 2021 |
| Metric | MESO | AMPL |
|---|---|---|
| Price | $14.52 | $13.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | N/A | ★ $13.42 |
| AVG Volume (30 Days) | 157.0K | ★ 1.4M |
| Earning Date | 02-26-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $343,214,000.00 |
| Revenue This Year | $629.74 | $17.43 |
| Revenue Next Year | $30.65 | $14.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 14.68 |
| 52 Week Low | $13.05 | $5.51 |
| 52 Week High | $21.50 | $14.76 |
| Indicator | MESO | AMPL |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 53.64 |
| Support Level | $14.18 | $6.05 |
| Resistance Level | $16.06 | $13.58 |
| Average True Range (ATR) | 0.42 | 0.67 |
| MACD | -0.08 | -0.09 |
| Stochastic Oscillator | 13.93 | 56.01 |
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.
Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.